BMNR (NYSE: BMNR) holder plans sale of 152,044 common shares via UBS

Rhea-AI Filing Summary

A shareholder of BMNR has filed a Form 144/A to sell up to 152,044 common shares through UBS Securities LLC on the NYSE, with an aggregate market value of about $5,429,000.00. The filing notes that there were 384,067,823 shares of this class outstanding at the time of the notice.

The shares to be sold were originally acquired on 08/31/2022 as GP compensation from the issuer, with 250,044 shares received on that date. The form also lists sales in the past three months for the same issuer’s stock, including 50,000 common shares sold by Jonathan Bates for $2,389,663.00 and 100,000 common shares sold by Progression Asset Management for $4,779,326.00, both on 09/22/2025. The signer represents that they are not aware of undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK
Filer CCC
Previous Accession Number Of The Filing
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Securities LLC 11 Madison Avenue New York NY 10010	152044	5429000.00	384067823	12/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/31/2022	GP COMPENSATION	ISSUER			250044	08/31/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan Bates 10845 Griffith Peak Drive Las Vegas NV 89135	Common	09/22/2025	50000	2389663.00
Progression Asset Management 2018 Vine Street Los Angeles CA 90068	COMMON	09/22/2025	100000	4779326.00

144/A: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many BMNR shares are planned to be sold under this Form 144/A?

The notice covers the planned sale of 152,044 common shares of BMNR through a broker.

What is the aggregate market value of the BMNR shares to be sold?

The filing reports an aggregate market value of about $5,429,000.00 for the 152,044 BMNR common shares to be sold.

Which broker will handle the BMNR share sale and on which exchange?

The BMNR shares are to be sold through UBS Securities LLC on the NYSE.

How many BMNR shares were outstanding when this notice was filed?

The filing states there were 384,067,823 common shares of the issuer outstanding when the notice was prepared.

When and how were the BMNR shares being sold originally acquired?

The common shares were acquired on 08/31/2022 as GP compensation from the issuer, with 250,044 shares received on that date.

What BMNR share sales occurred in the past three months before this notice?

The form lists two sales on 09/22/2025: Jonathan Bates sold 50,000 common shares for $2,389,663.00, and Progression Asset Management sold 100,000 common shares for $4,779,326.00.

What representation does the seller make about BMNR in this Form 144/A?

The seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.